文献速递产科母胎医学

初产妇孕早期早产型子痫前期筛查阳性者的妊娠结局:大产科综合征队列研究

Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2020-08-07

该前瞻性队列研究纳入4575名孕11–14周初产妇,按胎儿医学基金会算法计算早产型子痫前期风险,以1/70和1/100为切点分组,评估胎盘介导并发症的预测价值。结果显示筛查阳性者早产型子痫前期及其他严重胎盘介导并发症风险更高,约每10名高风险者中1人发生至少1种严重胎盘介导并发症。

要点

  • 孕早期早产型子痫前期筛查阳性初产妇,早产型子痫前期及其他严重胎盘介导并发症风险更高。
  • 切点1/70假阳性率10%时,可正确预测55%早产型子痫前期和37%胎儿死亡。
  • 切点1/100假阳性率15%时,可正确预测69%早产型子痫前期和53%胎儿死亡。

核心结论

  • 孕早期胎儿医学基金会早产型子痫前期筛查阳性的初产妇,早产型子痫前期及其他严重胎盘介导妊娠并发症风险更高。
  • 约每10名被胎儿医学基金会算法识别为高风险的女性中,1人发生至少1种严重胎盘介导妊娠并发症。

研究设计与样本

  • 前瞻性队列研究,纳入孕11–14周初产妇,最终分析4575名完整观察者。
  • 采集母亲特征、平均动脉血压、血清生物标志物(妊娠相关血浆蛋白A、胎盘生长因子、可溶性fms样酪氨酸激酶-1)及子宫动脉搏动指数均值,按胎儿医学基金会算法计算早产型子痫前期风险。
  • 预测风险按1/70和1/100两个切点分为阳性或阴性,计算胎盘介导并发症的检出率、假阳性率及阳性/阴性预测值。

主要发现

  • 494名(10.8%)早产型子痫前期估计风险≥1/70,728名(15.9%)风险≥1/100。
  • 切点1/70在10%假阳性率下,可正确预测27%子痫前期、55%早产型子痫前期、18%小于胎龄儿、24%严重小于胎龄儿、37%胎儿死亡。
  • 切点1/100在15%假阳性率下,可正确预测35%子痫前期、69%早产型子痫前期、25%小于胎龄儿、30%严重小于胎龄儿、53%胎儿死亡。
  • 早产型子痫前期筛查≥1/70的阳性预测值:早产型子痫前期3%、复合结局32%、严重复合结局9%。

关键数值与推荐

  • 早产型子痫前期风险切点1/70:假阳性率10%,检出率分别为子痫前期27%、早产型子痫前期55%、小于胎龄儿18%、严重小于胎龄儿24%、胎儿死亡37%。
  • 早产型子痫前期风险切点1/100:假阳性率15%,检出率分别为子痫前期35%、早产型子痫前期69%、小于胎龄儿25%、严重小于胎龄儿30%、胎儿死亡53%。
  • 小于胎龄儿定义为出生体重<第10百分位,严重小于胎龄儿为<第3百分位。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Fetal Medicine Foundation proposed a competing risks model for early identification of women at a high risk of preterm preeclampsia, typically associated with deep placentation disorders. The Great Obstetrical Syndromes include a spectrum of pregnancy complications (preeclampsia, intrauterine growth restriction, preterm birth, late spontaneous abortion, and abruptio placentae) that are also associated with deep placentation disorders. OBJECTIVE: This study aimed to estimate the rate of placenta-mediated pregnancy complications in nulliparous women with a positive first-trimester Fetal Medicine Foundation preterm preeclampsia screening test. STUDY DESIGN: We conducted a prospective cohort study of nulliparous women recruited at 11 to 14 weeks of gestation. Maternal characteristics, mean arterial blood pressure, levels of maternal serum biomarkers (pregnancy-associated plasma protein-A, placental growth factor, and soluble fms-like tyrosine kinase-1), and mean uterine artery pulsatility index were obtained to calculate the risk of preterm preeclampsia according to the Fetal Medicine Foundation algorithm. The predicted risks were dichotomized as a positive or negative test according to 2 risk cutoffs (1 in 70 and 1 in 100). The detection rate, false-positive rate, and positive and negative predictive values were calculated for placenta-mediated complications, including preeclampsia, small for gestational age (birthweight <10th percentile), fetal death, preterm birth, and a composite outcome, including any of the foregoing. The same analyses were computed for a composite of severe outcomes, including preterm preeclampsia, severe small for gestational age (less than third percentile), and fetal death. RESULTS: We included 4575 participants with complete observations, of whom 494 (10.8%) had an estimated risk of preterm preeclampsia of ≥1 in 70 and 728 (15.9%) had a risk of ≥1 in 100. The test based on a risk cutoff of 1 in 70 could have correctly predicted up to 27% of preeclampsia, 55% of preterm preeclampsia, 18% of small for gestational age, 24% of severe small for gestational age, and 37% of fetal deaths at a 10% false-positive rate. The test based on a cutoff of 1 in 100 could have predicted correctly up to 35% of preeclampsia, 69% of preterm preeclampsia, 25% of small for gestational age, 30% of severe small for gestational age, and 53% of fetal deaths at a 15% false-positive rate. The positive predictive value of a screening test for preterm preeclampsia of ≥1 in 70 was 3% for preterm preeclampsia, 32% for the composite outcome, and 9% for the severe composite outcome. CONCLUSION: Nulliparous women with a first-trimester positive preterm preeclampsia Fetal Medicine Foundation screening test are at a higher risk of both preterm preeclampsia and other severe placenta-mediated pregnancy complications. Approximately 1 woman of 10 identified as high risk by the Fetal Medicine Foundation algorithm developed at least 1 severe placenta-mediated pregnancy complication.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Boutin A, Guerby P, Gasse C, et al. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Am J Obstet Gynecol. 2020. PMID: 32777265. doi:10.1016/j.ajog.2020.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。